Reva Basho
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain Metastases (NCT04512261) | Reva Basho | 2022-06-01 |
Track Reva Basho automatically
Every clearance here is in the API, with alerts when new ones post.